NEWS
Lenmeldy——The most expensive drug in the word at present
Time: 2024-03-26
Wuxi Further Pharmaceutical Co.,Ltd.
Add: Huishan Life Science and Technology Industrial Park, Huishan District, Wuxi, China
Whatsapp: + 86 18036885286; Email: wuxifurther@gmail.com
Lenmeldy——The most expensive drug in the word at present
Worldwide, the therapeutics market is already flooded with therapies that cost more than $1 million per dose. At least 10 drugs (As following table ) have reached this milestone, mainly gene therapies, but also small molecule drug modalities. Recently, the one-time gene therapy Lenmeldy for early-onset metachromatic leukodystrophy (MLD) of Orchard Therapeutics has been approved by the FDA for sale, priced at $4.25 million, raising the price of the world's most expensive drug by 21%.
Drug name |
Price/Dose(Million $) |
Indications |
Manufacturers |
Approval time |
Therapy Methods |
|
Lenmeldy |
4.25 |
Metachromatic Leukodystrophy(MLD) |
Orchard Therapeutics |
2024.3.18 |
Gene therapy |
|
Hemgenix |
3.50 |
Hemophilia B |
CSL Behring and uniQure |
2022.11.22 |
Gene therapy |
|
Skysona |
3.00 |
CALD |
Bluebird Bio |
2022.9.18 |
Gene therapy |
|
Zynteglo |
2.80 |
βThalassemia |
Bluebird Bio |
2022.8.17 |
Gene therapy |
|
Zolgensma |
2.10 |
SMA |
Nuohua |
2019.5.26 |
Gene therapy |
|
Lamzede |
1.46 |
Alpha-mannoside storage syndrome |
Chiesi |
2023.2.16 |
Enzyme replacement therapy |
|
Myalept |
1.26 |
Systemic lipodystrophy |
Chiesi Farmaceutici |
2014.2.25 |
Protein |
|
Sohonos |
1.40 |
FOP |
Ipsen |
2023.8.16 |
Micromolecule |
|
Zokinvy |
1.00 |
Hutchinson-Gilford |
EigerBioPharmaceuticals |
2020.11.20 |
Micromolecule |
|
Danyelza |
1.00 |
Refractory neuroblastoma in bone or bone marrow |
Y-mAbs Therapeutics |
2020.11.25 |
McAb(monoclonal antibody) |
About us | R&D And Services | Products | Manufacturing Center | News | Downloads | Contact us | 中文版
Copyright(C)2022, Wuxi Further Pharmaceutical Co., Ltd. All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 备案序号:苏ICP备14012706号